trial

Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

NCTId NCT00400166
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 71 (actual)
Sponsored by Yale University
Primary completion 2009-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
71 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2006-12
Primary completion
2009-05
Eligibility
ALL · 18 Years · 80 Years

Interventions & indications

Drugs
Recovery Mentor

Sponsors

Yale UniversityLead Sponsor
Connecticut State, Department of Mental Health and Addiction ServicesCollaborator
Eli Lilly and CompanyCollaborator

Investigators

1
William H Sledge, MDPrincipal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
71
Phase
NA
Primary Completion Date
2009-05
Status
COMPLETED
relationships
The graph out of here
drug
Recovery Mentor
drug
lead_sponsor
Yale University
company
collaborator
Connecticut State, Department of Mental Health and Addiction Services
company
Eli Lilly and Company
company
indication
Bipolar Disorder
indication
Psychotic Depression
indication
Schizoaffective Disorder
indication
investigator
William H Sledge, MD
person